The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin. (Q35208747)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 July 2014

Language	Label	Description	Also known as
English	The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin.	scientific article published on 17 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

pharmacokinetics

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Vladimir Tolmachev

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

10

object named as

Mats Larhed

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Zohreh Varasteh

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ulrika Rosenström

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Irina Velikyan

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mohamed Altai

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hadis Honarvar

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Maria Rosestedt

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Gunnar Lindeberg

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jens Sörensen

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

0 references

publication date

17 July 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

10455-10472

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

copyright license

Creative Commons Attribution 4.0 International

17 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Gastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Pharmacology and neurochemistry of bombesin-like peptides

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Chemistry for peptide and protein PEGylation

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

PEGylation, successful approach to drug delivery

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

The impact of PEGylation on biological therapies

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Peptide and protein PEGylation: a review of problems and solutions

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Pegvisomant: structure and function

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Ligand binding assays at equilibrium: validation and interpretation

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Detecting ligand interactions with G protein-coupled receptors in real-time on living cells.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190710455

21 January 2018

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A branched monomethoxypoly(ethylene glycol) for protein modification

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25036155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/MOLECULES190710455

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036155%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35208747&oldid=2143347991"